Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Rad17 phosphorylation is required for claspin recruitment and Chk1 activation in response to replication stress.

Molecular cell | Aug 4, 2006

The ATR-mediated checkpoint is not only critical for responding to genotoxic stress but also essential for cell proliferation. The RFC-related checkpoint protein Rad17, a phosphorylation substrate of ATR, is critical for ATR-mediated checkpoint signaling and cell survival. Here, we show that phosphorylation of Rad17 by ATR is important for genomic stability and restraint of S phase but is not essential for cell survival. The phosphomutant Rad17AA exhibits distinct defects in hydroxyurea- (HU) and ultraviolet- (UV) induced Chk1 activation, indicating that separate Rad17 functions are required differently in response to different types of replication interference. Although cells expressing Rad17AA can initiate Chk1 phosphorylation after HU treatment, they fail to sustain Chk1 phosphorylation after withdrawal of HU and are profoundly sensitive to HU. Importantly, we found that phosphorylated Rad17 interacts with Claspin and regulates its phosphorylation. These findings reveal a phosphorylation-dependent function of Rad17 in an ATR-Rad17-Claspin-Chk1-signaling cascade that responds to specific replication stress.

Pubmed ID: 16885023 RIS Download

Mesh terms: Adaptor Proteins, Signal Transducing | Ataxia Telangiectasia Mutated Proteins | Cell Cycle | Cell Cycle Proteins | Cell Line | Cell Proliferation | Cell Survival | Checkpoint Kinase 1 | Chromatin | DNA Damage | DNA Replication | Genomic Instability | HCT116 Cells | Histones | Humans | Hydroxyurea | Mutation | Phosphorylation | Protein Binding | Protein Kinases | Protein-Serine-Threonine Kinases | S Phase | Transfection | Ultraviolet Rays

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.